Your new experience awaits. Try the new design now and help us make it even better

REVIEW article

Front. Oncol.

Sec. Thoracic Oncology

Volume 15 - 2025 | doi: 10.3389/fonc.2025.1550075

This article is part of the Research TopicProgress in Molecular Mechanisms and Targeted Therapies for Solid Tumor MicroenvironmentsView all 9 articles

Endoplasmic reticulum stress in lung cancer

Provisionally accepted
Donghuan  ZhangDonghuan Zhang1*Lanlan  LinLanlan Lin2Hui  JinHui Jin1Huajun  MaoHuajun Mao1Luying  WangLuying Wang1Wenwen  MaWenwen Ma1Zhenghong  LaoZhenghong Lao1*
  • 1Deqing People's Hospital, Huzhou, China
  • 2First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian Province, China

The final, formatted version of the article will be published soon.

Endoplasmic reticulum is the primary site of eukaryotic cells involved in biosynthesis, lipid metabolism, glucose metabolism, protein folding and secretion. Multiple factors in the tumor microenvironment may induce the accumulation of unfolded and misfolded proteins in the endoplasmic reticulum and trigger endoplasmic reticulum (ER) stress. Adaptive mechanisms including unfolded protein response (UPR) and endoplasmic reticulum associated degradation (ERAD) are activated in response to ER stress. Previous studies have revealed that ER stress may participate in epithelial mesenchymal transformation, apoptosis, metabolic regulation and drug resistance of lung cancer cells. Herein, we summarized the potential effects and regulatory mechanisms of ER stress on the biological process of lung cancer, which may provide scientific significance and clinical value for elucidating the adaptability of lung cancer cells under stress and developing novel targeted therapies.

Keywords: lung cancer, Tumor Microenvironment, Endoplasmic Reticulum Stress, Unfolded Protein Response, targeted therapy

Received: 22 Dec 2024; Accepted: 25 Aug 2025.

Copyright: © 2025 Zhang, Lin, Jin, Mao, Wang, Ma and Lao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Donghuan Zhang, Deqing People's Hospital, Huzhou, China
Zhenghong Lao, Deqing People's Hospital, Huzhou, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.